ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 375162 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 375162; 2) Community: the network communities that were significantly associated with the response to NSC 375162; 3) Molecule: the relationships between components within communities and NSC 375162; 4) MDR: the compounds that were significantly associated with the NSC 375162.

NSC Compound Enrichment Correlation
NSC 673348 9,10-Anthracenedione, 1-[(oxiranylmethyl)amino]- 0.00165587325865807 0.35235547
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.00165587325865807 0.22901459
NSC 740 Methotrexate 0.00165587325865807 0.35820811
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.00165587325865807 0.30883591
NSC 149967 Null 0.00165587325865811 0.45186869
NSC 135168 Null 0.00170676579199122 0.23177948
NSC 3262 2,5-Bis(ethylamino)hydroquinone 0.00170676579199122 0.32384848
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.00170676579199123 0.021173239
NSC 86368 Null 0.00170676579199123 0.22272031
NSC 610456 Camptothecin Derivative 0.0018088833864761 0.34460904
Total:112  Current:7    [First] [Prev] [Next] [Last]